Teaching Financial Management of Healthcare Organizations

Size: px

Start display at page:

Download "Teaching Financial Management of Healthcare Organizations"

Ross Boone
5 years ago
Views:

1 Last Saved: June 22, 2016 Armineh Zohrabian University of Missouri Telephone: Department of Health Management and Informatics One Hospital Drive, CE 707 Columbia, MO Employment Assistant Professor, Department of Health Management and Informatics, School of Medicine, University of Missouri, USA. July present Education Ph.D. Applied Economics, Auburn University, USA, 2000 M.S. Biophysics, Yerevan State University, Armenia, 1991 Research Interests Economics of risky health behaviors; Healthcare funding; Access to novel treatments; Economic evaluation of disease prevention and health promotion Teaching HMI 8472 HMI 8524 Financial Management of Healthcare Organizations Health Economics Professional Experience Ontario Public Service (OPS), Canada Senior Health Economist, Ministry of Health and Long-Term Care (MOHLTC), Health System Strategy and Policy Division, Economic Analysis and Evaluation Unit Conducted value for money & budget impact analyses Identified, synthesized and crystalized health economic literature and advised the leadership on the quality and strength of available evidence Reviewed and provided non-technical summary of economic analyses and reports on health topics of high priority for the Ontario government Supported preparation of cabinet submissions, specifically related to budget impact, value for money and affordability

2 Senior Funding Policy Analyst, Ministry of Health and Long-Term Care, Health System Information and Management Division, Funding Strategy and Policy Unit (Secondment) Led knowledge building activities, such as developing contacts and communication with other jurisdictions to enhance the evidence base for ministry s funding policies Identified, reviewed and summarized research, analyzed barriers and opportunities within new policy frameworks and prepared briefing notes, house notes and presentation materials Participated in workgroups related to ministry s health system funding reform Senior Policy Advisor, Ministry of Children and Youth Services, Strategic Policy and Planning Division, Planning and Partnership Unit (Secondment) Conducted analysis to help demonstrate economic rationale and value of public investment in social services for vulnerable children and youth Contributed to the development of innovative policies to increase effectiveness of social programs, including education, health and employment University of Western Ontario, Canada Senior Research Analyst, International Centre for Health Innovation, Richard Ivey School of Business Worked with the Centre s leadership to identify, assess and encourage adoption of innovative technologies Surveyed and synthesized literature, wrote research proposals, prepared analysis plans and protocols for Research Ethics Boards Cancer Care Ontario (CCO), Canada Senior Research Associate Contributed to research proposals related to cost-effectiveness of cancer drugs. Formulated purpose and rationale for economic research, surveyed and synthesized literature, checked internal (mathematical logic) and external consistency (to ensure that results made intuitive sense, or counter-intuitive results could be fully explained) of decision models Investigated methods for estimating comprehensive costs of cancer, with a focus on economic burden to patients and families throughout the continuum of care Centers for Disease Control and Prevention (CDC), USA Health Economist, Analytic Methods Team, Division of Adult and Community Health (DACH), National Center for Chronic Disease Prevention and Health Promotion, CDC ( ) As the sole health economist of the Division, maintained expertise in state of the art analytic methods regarding economics of chronic diseases, mentored professional staff, provided scientific feedback, guidance and advice to the Division on research needs and methods in economics as it applied to population health. Provided input 2

3 in the development of strategic research agenda focusing on summary measures of population health and economics of cardiovascular diseases. Due to wider interest and relevance, these efforts resulted in peer-reviewed publications As the technical monitor and project officer for the U.S. Burden of Disease study - a CDC and Harvard University collaboration, monitored project progress and ensured that project benchmarks were met in a timely manner. Systematically provided a critical link between Harvard University and CDC scientists Displayed an ability to work effectively on a contentious and controversial research project by identifying the varying sides of the dispute and contributing toward building positive relationship to achieve valid analytic methods As the CDC Representative to inter-agency working groups on the development of summary measures of population health and quality of life issues, presented methods and results of funded projects to internal and external stakeholders Acted as the key CDC contact person to convene a CDC workshop (June 2008), in collaboration with the National Institutes of Health (NIH), to generate data for new disability weights for an international initiative to estimate burden of diseases. Was invited to co-author an article in the Encyclopedia of Medical Decision-Making on Disability Adjusted Life Years Systematically reviewed and managed CDC grants and was a member of CDC Objective Review Panels to allocate federal funding to state health departments and university researchers Health Economist and Steven M. Teutsch Prevention Effectiveness Fellow, Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases (NCID), CDC ( ) As the principal investigator for the first cost study of West Nile virus (WNV) epidemic (2002) and the first cost-effectiveness study of WNV vaccination (2003): Wrote the detailed protocol for the CDC Institutional Review Board (IRB) clearance Co-designed and developed a patient survey to assess comprehensive costs of WNV illness Prepared and managed the CDC contract for administering the patient survey from conception to final deliverables As the lead of the CDC WNV outbreak investigation economics team: Collaborated with CDC epidemiology and surveillance teams, as well as professional staff of state/local health departments and healthcare delivery system Designed and coordinated collection of health economic data Conducted in-depth analysis related to cost of illness and economic benefits of prevention programs, using decision analysis software (@RISK by Palisade) and probabilistic modeling tools such as Monte-Carlo simulations and probabilistic sensitivity analysis 3

4 U.S. Department of Agriculture (USDA) and International Plant Genetic Resources Institute (IPGRI) Visiting Scientist, Economic Research Service (ERS) Developed methods and applications for estimating economic costs and benefits from the exploration of genetic resources in search of improved resistance to pests and pathogens Co-designed and developed an international survey on the demand for germplasm preserved in the U.S. National Germplasm System Professional Development Inside Congress: Understanding the Legislative Process. Brookings Executive Education. September 21-25, 2009 Graduate studies in public administration and applied economics, Hubert H. Humphrey School of Public Affairs and Department of Applied Economics, University of Minnesota, Minneapolis/St. Paul, USA Awards and Fellowships Honor Award Certificate. National Center for Infectious Diseases. CDC Steven M. Teutsch Prevention Effectiveness Fellowship. CDC Norman J. Doorenbos Award as Outstanding Graduate Student. Graduate School. Auburn University Outstanding International Graduate Student. College of Agriculture. Auburn University Edmund Muskie Fellowship in Public Administration. United States Information Agency Peer-Reviewed Publications Ferdinand KC, Orenstein D, Hong Y, Journigan JG, Trogdon J, Bowman J, Zohrabian A, et al. Health economics of cardiovascular disease: Defining the research agenda. CVD Prevention and Control. 2011, Vol. 6, Issue 3, Zohrabian A. Clinical and economic considerations of anti-obesity treatment: a review of orlistat. ClinicoEconomics and Outcomes Research. 2010, 2010:2, Zohrabian A, Philipson TJ. External costs of risky health behaviors associated with leading actual causes of death in the U.S.: a review of the evidence and implications for future research. International Journal of Environmental Research and Public Health. 2010, 7, McKenna MT, Zohrabian A. U.S. burden of disease past, present and future. Annals 4

5 of Epidemiology. Vol. 19, Issue 3, Pages March 2009 Grosse S, Zohrabian A. Disability Adjusted Life Years (DALYs). In Encyclopedia of Medical Decision Making. Editor Kattan M. SAGE Publications. New York. August 2009 Zohrabian A, Hayes EB, Petersen LR. Cost-effectiveness of West Nile virus vaccination from a societal perspective. Emerging Infectious Disease. 12(3): March Available from Zohrabian A. The long-term effects and economic consequences of treatments for obesity: work in progress. Comment. The Lancet. Volume 365 Number 9454, pp January 8-14, 2005 Zohrabian A, Meltzer MI, Ratard R, et al. West Nile virus economic impact, Louisiana, Emerging Infectious Diseases. 10(10): October Available from Zohrabian A, Traxler G, Caudill S, Smale M. Valuing Pre-Commercial Genetic Resources: A Maximum Entropy Approach. American Journal of Agricultural Economics. Vol. 85, No. 2. pp May 2003 Selected Presentations/Lectures in Health Economics University of Toronto. Institute of Health Policy, Management and Evaluation. Guest Lecturer. Economic Evaluation Methods for Health Services Research (HAD5730). Pharmacogenomics. November 7, 2012 University of Toronto. Guest Lecturer. Economic Evaluation Methods for Health Services Research (HAD5730). Uncertainty and Probabilistic Analysis. November 2010 Toronto Health Economics Network (THEN) Seminar Series. Analytical Framework for Estimating External Costs of Health Behaviors. October 2010 Cancer Care Ontario. Lunch and Learn Seminar Series. Can Economic Tools Help Change Risky Health Behaviors? Toronto, ON. September 1, 2010 Centers for Disease Control and Prevention. Health Economics Research Group (HERG) Seminar. External Costs of Risky Health Behaviors Associated With Leading Actual Causes of Death in the U.S. May 1, Atlanta, GA Second Biennial Conference of the American Society of Health Economists (ASHE). The Role of Economics in Cardiovascular Disease Prevention and Health Promotion. June 25, Durham, NC NIH Workshop for the Interagency Workgroup on Summary and Outcome Measures. Disease Burden Attributable to Risk Factors Project. July 12, Washington, DC 5

6 National Institutes of Health (NIH) Burden of Muscle Disease Workshop. Disability Adjusted Life Years Measurements in Australia. January 27, Bethesda, MD CDC s Short-Course for the Steven Teutsch Post-Doctoral Fellows in Prevention Effectiveness. Methods and Data Used in the US Burden of Disease Study. Fall th Annual Meeting of the Society for Medical Decision Making. Short-Course: Use of Quality of Life and Burden of Disease Data for Planning, Resource Allocation and Evaluation. October 17, Atlanta, GA Fourth World Congress of the International Health Economics Association. "Cost Analysis Framework for Mosquito-Borne Diseases." June 15-18, San Francisco, CA Fourth National Conference on West Nile Virus in the United States. "Economic Costs of the 2002 WN Epidemic in Louisiana and Expected Benefits from Prevention Programs." February 9-12, New Orleans, LA Committee Membership Co-chaired a sub-committee of the National Forum on Heart Disease and Stroke Prevention, USA, to organize an Economics Symposium to define the research agenda for health economics of cardiovascular diseases Member of the U.S. Interagency Working Group on Summary and Outcome Measures of Health Member of the Scientific Committee for the 6th and 7th Congresses of the International Health Economics Association (ihea), Review of Articles for Scientific Journals and Government Grants Peer reviewer for The Lancet; Obesity Research; Journal of the American College of Nutrition; PLoS Neglected Tropical Diseases; Population Health Metrics Objective reviewer, CDC, Objective Review Panels for: o CDC s Funding Opportunity Announcement (FOA) DP09-904: "National Sudden Unexpected Infant Death Case Registry: A Pilot Study" June 2009 o Request for Application (RFA) DDT - DP Using Traditional Foods and Sustainable Ecological Approaches for Health Promotion and Diabetes Prevention in American Indian/Alaska Native (AI/AN) Communities. July 2008 o Request for Application (RFA) DP State Public Health Approaches to Arthritis. April 2008 o Request for Application (RFA) #05009 Population-Based Birth Defects Surveillance Programs and the Utilization of Surveillance Data by Public Health Programs. December

7 Served as a project officer and technical monitor for CDC-RFA-DP09EM-901, which included two projects: Healthy Kids and Families by Roberts Family Development Center, California; and Families Helping Families Education Program for Individuals and Families Dealing with Alcohol Addiction Recovery by Clearbrook, Inc. Pennsylvania Interagency peer reviewer representing CDC for the Food and Drug Administration s proposed rule Prevention of Salmonella Enteritidis in Shell Eggs during Production. January

Erica Alley. St. Paul, MN 55105

Erica Alley. St. Paul, MN 55105 Erica Alley 6332 137 th St W Apple Valley, MN 55124 ASL and Interpreting Department Cell Phone: 703-286-9860 2004 Randolph Ave Email: ELAlley@stkate.edu St. Paul, MN 55105 Education Ph.D., Washington,